Meeder Asset Management Inc Incyte Corp Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

A detailed history of Meeder Asset Management Inc transactions in Incyte Corp stock. As of the latest transaction made, Meeder Asset Management Inc holds 2,811 shares of INCY stock, worth $205,568. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,811

Holding current value

$205,568

% of portfolio

0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$57.33 - $68.61 $161,154 - $192,862	2,811 New	2,811 $185,000
Q1 2024 May 07, 2024	BUY	$56.55 - $66.59 $27,483 - $32,362	486 New	486 $27,000
Q1 2023 May 15, 2023	SELL	$70.23 - $86.01 $201,068 - $246,246	-2,863 Reduced 96.01%	119 $8,000
Q4 2022 Feb 14, 2023	SELL	$67.18 - $84.11 $109,839 - $137,519	-1,635 Reduced 35.41%	2,982 $239,000
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $484,371 - $606,452	-7,319 Reduced 61.32%	4,617 $307,000
Q2 2022 Aug 08, 2022	BUY	$66.18 - $83.18 $500,982 - $629,672	7,570 Added 173.39%	11,936 $907,000
Q1 2022 May 10, 2022	BUY	$66.02 - $79.71 $288,243 - $348,013	4,366 New	4,366 $347,000
Q4 2021 Feb 11, 2022	SELL	$63.34 - $74.11 $1.34 Million - $1.56 Million	-21,077 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$68.67 - $84.02 $1.16 Million - $1.42 Million	16,865 Added 400.4%	21,077 $1.45 Million
Q2 2021 Aug 09, 2021	SELL	$79.87 - $87.53 $265,487 - $290,949	-3,324 Reduced 44.11%	4,212 $354,000
Q1 2021 Apr 28, 2021	BUY	$76.02 - $100.5 $543,086 - $717,972	7,144 Added 1822.45%	7,536 $612,000
Q4 2020 Feb 09, 2021	BUY	$80.74 - $97.7 $8,881 - $10,747	110 Added 39.01%	392 $34,000
Q3 2020 Nov 02, 2020	BUY	$85.07 - $109.69 $8,847 - $11,407	104 Added 58.43%	282 $25,000
Q2 2020 Aug 11, 2020	SELL	$74.18 - $108.93 $977,247 - $1.44 Million	-13,174 Reduced 98.67%	178 $19,000
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $758,791 - $1.03 Million	-12,010 Reduced 47.35%	13,352 $978,000
Q4 2019 Feb 13, 2020	BUY	$73.04 - $95.72 $369,582 - $484,343	5,060 Added 24.92%	25,362 $2.22 Million
Q3 2019 Oct 17, 2019	BUY	$72.82 - $86.52 $499,472 - $593,440	6,859 Added 51.02%	20,302 $1.51 Million
Q2 2019 Aug 05, 2019	SELL	$73.52 - $88.7 $631,242 - $761,578	-8,586 Reduced 38.98%	13,443 $1.14 Million
Q1 2019 Apr 16, 2019	BUY	$63.56 - $88.17 $1.08 Million - $1.49 Million	16,942 Added 333.05%	22,029 $1.9 Million
Q4 2018 Jan 17, 2019	BUY	$58.5 - $69.94 $266,233 - $318,296	4,551 Added 849.07%	5,087 $324,000
Q3 2018 Nov 02, 2018	BUY	$61.75 - $74.23 $9,200 - $11,060	149 Added 38.5%	536 $0
Q2 2018 Jul 24, 2018	BUY	$60.85 - $83.98 $14,299 - $19,735	235 Added 154.61%	387 $0
Q1 2018 May 03, 2018	SELL	$83.06 - $100.98 $86,382 - $105,019	-1,040 Reduced 87.25%	152 $13,000
Q4 2017 Feb 02, 2018	SELL	$93.56 - $116.6 $206,393 - $257,219	-2,206 Reduced 64.92%	1,192 $112,000
Q3 2017 Oct 20, 2017	BUY	$109.15 - $138.27 $370,891 - $469,841	3,398	3,398 $397,000

Others Institutions Holding INCY

# of Institutions

645

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account

Meeder Asset Management Inc Incyte Corp Transaction History